no statement of use filed
on 06 May 2024
Last Applicant/ Owned by
103 Montgomery Street, Suite 150
San Francisco
CA
94129
Serial Number
90127832 filed on 20th Aug 2020
Registration Number
N/A
Correspondent Address
San Francisco, CA 94129
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
scientific research for medical purposes in the field of oncology; research and development of therapeutics for the treatment of cancer; research and development in the field of small molecule therapeutics; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development therapeutic Read More
scientific research for medical purposes in the field of oncology; research and development of therapeutics for the treatment of cancer; research and development in the field of small molecule therapeutics; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development
N/A
N/A
therapeutic pharmaceuticals for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; anti-cancer preparations; pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the endocrine system; pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; dermatological pharmaceutical preparations; pharmaceutical preparations for use in hematology, namely, for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of kidney diseases; antibacterial pharmaceuticals; pharmaceutical preparations for the prevention and treatment of allergies
N/A
N/A
No 90127832
No Service Mark
No
No
No
No
No
No
No
No
No
24.17.25 -
Other notational signs and symbols, including pH, hazardous materials symbols, degree sign(°), pound sign(#), equal signs(=), and other mathematical symbols
26.01.01 -
Circles as carriers or as single line borders
26.17.12 -
Chevrons and angles
Status Date | Action Taken |
---|---|
06th May 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
06th May 2024 | ABANDONMENT - NO USE STATEMENT FILED |
06th Feb 2024 | WITHDRAWAL OF ATTORNEY GRANTED |
06th Feb 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
29th Sep 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
28th Sep 2023 | SOU EXTENSION 5 GRANTED |
28th Sep 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
21st Sep 2023 | SOU EXTENSION 5 FILED |
21st Sep 2023 | SOU TEAS EXTENSION RECEIVED |
07th Feb 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |